Prothena Corp Public (PRTA) Other Non-Current Liabilities (2014 - 2022)
Prothena Corp Public's (PRTA) quarterly Other Non-Current Liabilities came in at $553000.0 in Q4 2022, little changed year-on-year from $553000.0 in Q4 2021, and little changed quarter-over-quarter from $553000.0 in Q3 2022.
Prothena Corp Public (PRTA) Other Non-Current Liabilities (2014 - 2022) Analysis & Trends
Prothena Corp Public's Other Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $553000.0 for Q4 2022.
- On a quarterly basis, Other Non-Current Liabilities changed 0.0% year-over-year to $553000.0 in Q4 2022; TTM through Dec 2022 was $553000.0, a 0.0% change from a year earlier, with the FY2022 full-year figure at $553000.0, changed 0.0% from the prior year.
- Other Non-Current Liabilities held at $553000.0 in Q4 2022 per PRTA's latest filing, from $553000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $553000.0 in Q3 2018 and bottomed at $553000.0 in Q3 2018.
- The 5-year median for Other Non-Current Liabilities is $553000.0 (2018), against an average of $553000.0.
- Biggest YoY gain for Other Non-Current Liabilities was 0.0% in 2019; the steepest drop was 0.0% in 2019.
- Year by year, Other Non-Current Liabilities stood at $553000.0 in 2018, then changed by 0.0% to $553000.0 in 2019, then changed by 0.0% to $553000.0 in 2020, then changed by 0.0% to $553000.0 in 2021, then changed by 0.0% to $553000.0 in 2022.
- Per Business Quant, the three latest PRTA Other Non-Current Liabilities figures stand at $553000.0 (Q4 2022), $553000.0 (Q3 2022), and $553000.0 (Q2 2022).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Prothena Corp Public | 458.13 Mn | 128.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 553,000.00 |
| Sep 30, 2022 | 553,000.00 |
| Jun 30, 2022 | 553,000.00 |
| Mar 31, 2022 | 553,000.00 |
| Dec 31, 2021 | 553,000.00 |
| Sep 30, 2021 | 553,000.00 |
| Jun 30, 2021 | 553,000.00 |
| Mar 31, 2021 | 553,000.00 |
| Dec 31, 2020 | 553,000.00 |
| Sep 30, 2020 | 553,000.00 |
| Jun 30, 2020 | 553,000.00 |
| Mar 31, 2020 | 553,000.00 |
| Dec 31, 2019 | 553,000.00 |
| Sep 30, 2019 | 553,000.00 |
| Jun 30, 2019 | 553,000.00 |
| Mar 31, 2019 | 553,000.00 |
| Dec 31, 2018 | 553,000.00 |
| Sep 30, 2018 | 553,000.00 |
| Dec 31, 2016 | 98,000.00 |
| Jun 30, 2016 | 98,000.00 |